Form EFFECT Protalix BioTherapeutics
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | August 22, 2025 4:00 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Luvs Is Helping Parents With Affordable Diapers That Actually Work
- From Abu Dhabi to the World: Chery Group Reaffirms Its Commitment to FREELANDER and a New Benchmark for Premium Brands
- Crypto Arbitrage Is a Cash Question Before It Is a Price Question
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
